Delhi-based Eli Lilly & Company (India) Pvt Ltd has cut by 40 per cent the price of 'Xigris,' used for treating food poisoning in line with reduced customs duty.
"The prices of Xigri has come down from Rs 600,000 to Rs 325,000 for an individual of 60 kg," Eli Lilly medical director Ramananda S Nadig told reporters on Wednesday after announcing the launch of a five day 'surviving sepsis (food poisoning) campaign' with Indian Society of Critical Care Medicine (ISCCM).
The product is currently imported from the US and was introduced in India in October 2002, he said.
Eli Lilly brand manager Deepak Arora said Xigris has been used in treatment of 200 patients and 102 of those have survived. However, survival also depends upon the period of diagnosis and availability of critical care facilities.
The company has also provided 'compassionate doses' (free of cost) to 15 patients, he added.
© 2026